Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Lee, K. Woo, S. Kim, Hwiyoung Kim, K. Kwack, Z. Lee, H. Kim (2002)
The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.Bone, 30 1
P. Zhao, E. Hoffman (2004)
Embryonic myogenesis pathways in muscle regenerationDevelopmental Dynamics, 229
Mitchell Goldfarb (1996)
Functions of fibroblast growth factors in vertebrate development.Cytokine & growth factor reviews, 7 4
J. Zuo, Jin Jiang, C. Dolce, L. Holliday (2004)
Effects of basic fibroblast growth factor on osteoclasts and osteoclast-like cells.Biochemical and biophysical research communications, 318 1
S. Frenkel, M. Herskovits, I. Singh (1992)
Fibroblast growth factor: effects on osteogenesis and chondrogenesis in the chick embryo.Acta anatomica, 145 3
D. Ornitz, Jingsong Xu, Jennifer Colvin, D. McEwen, C. MacArthur, F. Coulier, G. Gao, M. Goldfarb (1996)
Receptor Specificity of the Fibroblast Growth Factor Family*The Journal of Biological Chemistry, 271
S. Vainikka, J. Partanen, P. Bellosta, F. Coulier, D. Birnbaum, C. Basilico, M. Jaye, K. Alitalo (1992)
Fibroblast growth factor receptor‐4 shows novel features in genomic structure, ligand binding and signal transduction.The EMBO Journal, 11
Y. Calle, G. Jones, C. Jagger, K. Fuller, M. Blundell, J. Chow, T. Chambers, A. Thrasher (2004)
WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption.Blood, 103 9
A. Montero, Y. Okada, M. Tomita, Masako Ito, H. Tsurukami, Toshitaka Nakamura, T. Doetschman, J. Coffin, M. Hurley (2000)
Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.The Journal of clinical investigation, 105 8
F. Fiore, J. Planche, P. Gibier, A. Sébille, O. Delapeyrière, D. Birnbaum (1997)
Apparent normal phenotype of Fgf6-/- mice.The International journal of developmental biology, 41 4
N. Su, Jing Yang, Yixia Xie, Xiaolan Du, Xiumin Lu, Z. Yin, L. Yin, H. Qi, Ling Zhao, Jian Feng, Lin Chen (2008)
Gain-of-function mutation of FGFR3 results in impaired fracture healing due to inhibition of chondrocyte differentiation.Biochemical and biophysical research communications, 376 3
M. Hurley, S. Lee, L. Raisz, P. Bernecker, J. Lorenzo (1998)
Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures.Bone, 22 4
S. Cool, R. Jackson, P. Pincus, I. Dickinson, V. Nurcombe (2002)
Fibroblast growth factor receptor 4 (FGFR4) expression in newborn murine calvaria and primary osteoblast cultures.The International journal of developmental biology, 46 4
F. Rousseau, P. Saugier, M. Merrer, A. Munnich, A. Delezoide, P. Maroteaux, J. Bonaventure, F. Narcy, M. Sanak (1995)
Stop codon FGFR3 mutations in thanatophoric dwarfism type 1Nature Genetics, 10
D. Chikazu, Y. Hakeda, N. Ogata, K. Nemoto, A. Itabashi, T. Takato, M. Kumegawa, Kozo Nakamura, H. Kawaguchi (2000)
Fibroblast Growth Factor (FGF)-2 Directly Stimulates Mature Osteoclast Function through Activation of FGF Receptor 1 and p42/p44 MAP Kinase*The Journal of Biological Chemistry, 275
C. Chenu, J. Pfeilschifter, G. Mundy, G. Roodman (1988)
Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures.Proceedings of the National Academy of Sciences of the United States of America, 85 15
W. Boyle, W. Simonet, D. Lacey (2003)
Osteoclast differentiation and activationNature, 423
Takashi Shimoaka, T. Ogasawara, Akiko Yonamine, D. Chikazu, H. Kawano, Kozo Nakamura, N. Itoh, H. Kawaguchi (2002)
Regulation of Osteoblast, Chondrocyte, and Osteoclast Functions by Fibroblast Growth Factor (FGF)-18 in Comparison with FGF-2 and FGF-10*The Journal of Biological Chemistry, 277
S. Pizette, F. Coulier, D. Birnbaum, O. Delapeyrière (1996)
FGF6 modulates the expression of fibroblast growth factor receptors and myogenic genes in muscle cells.Experimental cell research, 224 1
Alia Fakhry, C. Ratisoontorn, Charulatha Vedhachalam, I. Salhab, E. Koyama, P. Leboy, M. Pacifici, R. Kirschner, H. Nah (2005)
Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential.Bone, 36 2
D. Givol, A. Yayon (1992)
Complexity of FGF receptors: genetic basis for structural diversity and functional specificityThe FASEB Journal, 6
A. Raucci, P. Bellosta, R. Grassi, C. Basilico, A. Mansukhani (2008)
Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathwaysJournal of Cellular Physiology, 215
L. Hale, Yan Ma, R. Santerre (2000)
Semi-Quantitative Fluorescence Analysis of Calcein Binding as a Measurement of In Vitro MineralizationCalcified Tissue International, 67
Anne-Sophie Armand, I. Laziz, C. Chanoine (2006)
FGF6 in myogenesis.Biochimica et biophysica acta, 1763 8
C. Deng, A. Wynshaw-Boris, Fen Zhou, A. Kuo, P. Leder (1996)
Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone GrowthCell, 84
P. Lakkakorpi, H. Väänänen (1996)
Cytoskeletal changes in osteoclasts during the resorption cycleMicroscopy Research and Technique, 33
George Bridgeman, Murray Brookes (1996)
Blood supply to the human femoral diaphysis in youth and senescence.Journal of anatomy, 188 ( Pt 3)
O. Halevy, L. Cantley (2004)
Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.Experimental cell research, 297 1
M. Bosetti, E. Verné, Monica Ferraris, A. Ravaglioli, Mario Cannas (2001)
In vitro characterisation of zirconia coated by bioactive glass.Biomaterials, 22 9
Fibroblast growth factor‐6 (FGF‐6) is known to be the key ligand for fibroblast growth factor receptor 4 (FGFR4) during muscle regeneration but its role in bone has yet to be verified. FGFR signaling is known to be important in the initiation and regulation of osteogenesis, so in this study the actions of FGF‐6 on human osteoblasts and osteoclasts were investigated. Human primary osteoblasts (hOB) were used to study the effect of FGF‐6 on proliferation (by ATP quantification), signal transduction (by ERK and AKT phosphorylation), differentiation (by alkaline phosphatase activity, APA), and mineralization (by calcein staining). To study FGF‐6 activity on osteoclast differentiation, human bone marrow cells were used and tartrate‐resistant acid phosphatase (TRAP) multinucleated cells together with actin filaments arrangements were quantified. Human primary mature osteoclasts were used to evaluate the effect of FGF‐6 on osteoclast reabsorbing activity by reabsorbed pit measurements. FGF‐6 >10−9 M as FGF‐2 10−7 M induced hOB proliferation mediated by pERK together with a reduction in APA and reduced mineralization of the treated cells. Moreover FGF‐6 increased the formation of TRAP‐positive multinucleated cells in a dose‐dependent manner (maximal effect at 10−8 M). FGF‐6‐treated cells showed also a greater percentage of cells that formed typical osteoclast sealing zones. Mature osteoclasts cultured on dentine slice increased the area of reabsorption with a maximal effect of FGF‐6 at 10−12 M. FGF‐6 may be considered a regulator of bone metabolism as shown by its activity on both osteoblasts and osteoclasts. J. Cell. Physiol. 225: 466–471, 2010. © 2010 Wiley‐Liss, Inc.
Journal of Cellular Physiology – Wiley
Published: Nov 1, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.